“DDR allows capturing of breathing dynamics with relative ease compared to PFTs,” says Thomas John Pisano, MD, PhD, Neurology Resident at the University of Pennsylvania, and co-author of the article. “Using our AI-based software and DDR, we can generate digital PFT's (dPFTs) which might be used as surrogates for pulmonary function testing. We are excited about the ability to deploy this in emergency room, inpatient and intensive care medicine. I'm particularly interested in seeing if it will be helpful for patients with certain neuromuscular diseases such as myasthenia gravis. Unlike with PFTs, our software enables us to generate pulmonary strain plots, comparable to strain echocardiography. We are excited about exploring the utility of pulmonary strain radiography towards diagnosing dyspnea.”
“Konica Minolta congratulates Dr. Mary O’Sullivan, Dr. Valeria Santibanez, Dr. Thomas Pisano, Dr. Norma Braun and their Mount Sinai colleagues on the publication of their study showing the power of machine-learning tools to extract even more clinically useful information from DDR data,” says John Sabol, PhD, Clinical Research Manager, Konica Minolta Healthcare. “Chest radiography is typically acquired in the evaluation of pulmonary disorders. Adding a DDR acquisition to the chest radiograph provides additional functional data beyond a PFT, allowing for quantitative longitudinal studies of physiologic changes over time, and is less burdensome to patients who have breathing issues.”
About Konica Minolta Healthcare Americas, Inc.
Konica Minolta Healthcare is a world-class provider and market leader in medical diagnostic imaging and healthcare information technology. The company’s focus is to contribute to life changing advances through the transformation of primary imaging, allowing the invisible to be seen. Primary imaging, the most commonly used medical imaging technologies, include X-ray, ultrasound and imaging management systems. By advancing these readily available technologies, we can bring greater diagnostic capabilities to the greatest number of people.
With 150 years of endless innovation, imaging is in Konica Minolta’s DNA. From roots as a camera and film manufacturer, the company has cultivated its own technologies and continues to evolve techniques for visualizing what is not visible. Innovation allows the company to be a strong strategic partner, understanding what value means to customers and how Konica Minolta’s innovations can address specific needs and lead to better decisions, sooner.
Back to HCB News
